Baxter International (BAX)
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

Company profile
Ticker
BAX
Exchange
Website
CEO
Jose Almeida
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences • Embecta ...
SEC CIK
Corporate docs
Subsidiaries
Baxter Corporation • Baxter Healthcare Corporation • Baxter Pharmaceutical Solutions LLC • Baxter Sales and Distribution LLC • Cheetah Medical, Inc. • Gambro Renal Products, Inc. • Gambro UF Solutions, Inc. • Hill-Rom Holdings, Inc • Laboratorios Baxter S.A. • Synovis Life Technologies, Inc. ...
IRS number
360781620
BAX stock data
Press releases
Baxter to Host 2022 Investor Conference
10 May 22
Baxter Increases Dividend and Declares Quarterly Dividend
3 May 22
BAXTER HIGHLIGHTS NEW DATA AT SCCM CRITICAL CARE CONGRESS SHOWING HEMODYNAMIC MONITORING MAY HELP PREDICT PATIENT OUTCOMES
19 Apr 22
Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes
19 Apr 22
Medical Adhesive Market Analysis, Market Size, Competitive Strategies, Forecasts to 2028
30 Mar 22
Analyst ratings and price targets
Current price
Average target
$87.80
Low target
$77.00
High target
$100.00
Raymond James
Maintains
$85.00
Morgan Stanley
Maintains
$100.00
Wells Fargo
Maintains
$90.00
Keybanc
Maintains
$87.00
Goldman Sachs
Downgraded
$77.00
Calendar
28 Apr 22
17 May 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B | 2.3B |
Cash burn (monthly) | 219M | 73.92M | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 340.02M | 114.76M | n/a | n/a | n/a | n/a |
Cash remaining | 1.96B | 2.18B | n/a | n/a | n/a | n/a |
Runway (months of cash) | 8.9 | 29.5 | n/a | n/a | n/a | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 May 22 | David Brent Shafer | Common Stock, $1 par value | Grant | Acquire A | No | No | 0 | 2,481 | 0 | 2,481 |
10 May 22 | Peter M Wilver | Common Stock, $1 par value | Grant | Acquire A | No | No | 0 | 2,481 | 0 | 2,481 |
3 May 22 | Chen Thomas F | Common Stock, $1 par value | Grant | Acquire A | No | No | 0 | 2,706 | 0 | 15,740 |
Institutional ownership, Q4 2021
84.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1121 |
Opened positions | 152 |
Closed positions | 91 |
Increased positions | 347 |
Reduced positions | 385 |
13F shares | Current |
---|---|
Total value | 36.71B |
Total shares | 427.62M |
Total puts | 2.06M |
Total calls | 1.36M |
Total put/call ratio | 1.5 |
Largest owners | Shares | Value |
---|---|---|
Wellington Management | 49.65M | $4.26B |
BLK Blackrock | 40.11M | $3.44B |
Vanguard | 38.98M | $3.35B |
MS Morgan Stanley | 28.38M | $2.44B |
STT State Street | 21.61M | $1.86B |
Generation Investment Management | 21.17M | $1.82B |
Veritas Asset Management | 12.22M | $1.05B |
Geode Capital Management | 8.72M | $746.52M |
AMP Ameriprise Financial | 7.1M | $609.24M |
State Farm Mutual Automobile Insurance | 6.85M | $588.3M |
Financial report summary
?Competition
Axogen • ThermoGenesis • AIM ImmunoTech • Sangamo Therapeutics • United Health Products • Edwards Lifesciences • Curis • Lemaitre Vascular • Nephros • GlycoMimeticsManagement Discussion
- Net income attributable to Baxter stockholders for the three months ended March 31, 2022 totaled $71 million, or $0.14 per diluted share, compared to $298 million, or $0.58 per diluted share, for the three months ended March 31, 2021. The first quarter of 2022 is the first full quarter reflecting Hillrom results of operations after the December 13, 2021 acquisition. Net income for the three months ended March 31, 2022 included special items which decreased net income by $400 million, or $0.79 per diluted share, respectively, as further discussed below. Net income for the three months ended March 31, 2021 included special items which decreased net income by $88 million, or $0.18 per diluted share, as further discussed below.
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acknowledged, added, admitting, answer, assembled, Back, bariatric, birthing, Build, Canada, cardiology, climate, collection, competitor, compliant, confidence, conflict, constitute, conversion, denying, desire, desist, diagnose, entity, escalation, exceeded, extinguishment, female, field, fiscal, framework, freight, front, frozen, functional, geopolitical, ill, inflation, Inspector, installation, lack, legacy, Linet, Lira, macroeconomic, maternal, nonpublic, nosocomial, Omicron, outbound, parent, peak, pelvic, penalty, Pfizer, physical, pneumonia, political, preceding, precision, preferred, quantify, repaid, review, Russia, screening, sentence, serving, Sherman, situation, skin, specialty, subpoena, therapy, thousand, Turkey, Turkish, Ukraine, variety, video, vision, war, warranty, workforce, Zosyn
Removed:
allocating, appeal, applying, approach, assessing, aware, Baxalta, branded, cancer, chemotherapy, closed, combination, Concurrent, conspiracy, cooperate, covering, disaggregation, Division, doxorubicin, Eastern, exercise, existed, expire, extended, finalize, forma, geographical, German, GlaxoSmithKline, grand, improvement, institutional, Irvine, issuance, Johnson, jury, Justice, license, liposomal, managed, manufacturer, matter, medicine, met, moved, nausea, notified, occurred, output, parallel, Pennsylvania, permitted, positive, postponed, prejudice, pro, reallocate, reallocated, reallocation, recast, reduction, referred, region, relationship, relied, requested, restrict, restructure, saline, seeking, Shire, shortage, single, Specifically, TDS, testimony, upfront, voluntary, vomiting, weakening, York
Financial reports
Current reports
8-K
Material Modifications to Rights of Security Holders
6 May 22
8-K
Other Events
28 Apr 22
8-K
Baxter Reports First-quarter 2022 Results
28 Apr 22
8-K
Regulation FD Disclosure
22 Mar 22
8-K
Baxter Reports Fourth-quarter and Full-year 2021 Results
17 Feb 22
8-K
Creating ~$15 Billion Global Medtech Leader
13 Dec 21
8-K
Entry into a Material Definitive Agreement
2 Dec 21
8-K
Departure of Directors or Certain Officers
30 Nov 21
8-K
Entry into a Material Definitive Agreement
17 Nov 21
8-K
Regulation FD Disclosure
15 Nov 21
Registration and prospectus
424B3
Prospectus supplement
12 May 22
S-3
Shelf registration
28 Apr 22
S-8
Registration of securities for employees
13 Dec 21
S-3ASR
Automatic shelf registration
29 Jul 21
S-8
Registration of securities for employees
4 May 21
S-8
Registration of securities for employees
4 May 21
S-8 POS
Registration of securities for employees (post-effective amendment)
4 May 21
424B3
Prospectus supplement
14 Apr 21
S-4
Registration of securities issued in business combination transactions
7 Apr 21
Proxies
DEFR14A
Revised proxy
28 Mar 22
PX14A6G
Letter to shareholders
23 Mar 22
DEFA14A
Additional proxy soliciting materials
21 Mar 22
PRE 14A
Preliminary proxy
10 Mar 22
PX14A6G
Letter to shareholders
31 Mar 21
DEFA14A
Additional proxy soliciting materials
22 Mar 21
DEF 14A
Definitive proxy
22 Mar 21
DEFA14A
Additional proxy soliciting materials
21 Apr 20
DEFA14A
Additional proxy soliciting materials
31 Mar 20
Other
EFFECT
Notice of effectiveness
12 May 22
EFFECT
Notice of effectiveness
12 May 22
SD
Conflict minerals disclosure
1 Jun 21
EFFECT
Notice of effectiveness
15 Apr 21
CORRESP
Correspondence with SEC
11 Apr 21
UPLOAD
Letter from SEC
8 Apr 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
24 May 19
CERT
Certification of approval for exchange listing
21 May 19
SD
Conflict minerals disclosure
31 May 18
Ownership
4
BAXTER INTERNATIONAL / PETER M WILVER ownership change
12 May 22
3
BAXTER INTERNATIONAL / PETER M WILVER ownership change
12 May 22
4
BAXTER INTERNATIONAL / David Brent Shafer ownership change
12 May 22
3
BAXTER INTERNATIONAL / David Brent Shafer ownership change
12 May 22
4
BAXTER INTERNATIONAL / David S. Wilkes ownership change
5 May 22
4
BAXTER INTERNATIONAL / Amy McBride Wendell ownership change
5 May 22
4
BAXTER INTERNATIONAL / Cathy R Smith ownership change
5 May 22
4
BAXTER INTERNATIONAL / NANCY M SCHLICHTING ownership change
5 May 22
4
BAXTER INTERNATIONAL / Stephen N. Oesterle ownership change
5 May 22
4
BAXTER INTERNATIONAL / PATRICIA MORRISON ownership change
5 May 22
Patents
Utility
Apparatus for Extracorporeal Treatment of Blood and Method for Determining a Parameter Indicative of the Progress of an Extracorporeal Blood Treatment
12 May 22
An apparatus for extracorporeal treatment of blood (1) comprising a treatment unit, a blood withdrawal line, a blood return line, a preparation line and a spent dialysate line.
Utility
System and Method for Extending the Storage Duration of a Rechargeable Battery of an Infusion Pump
12 May 22
A method for extending the storage lifetime of a battery located in a device is disclosed.
Utility
Device and Method for the Delivery of a Thrombin Activated Fibrin Sealant
12 May 22
The invention relates to a dispenser of a sealant for hemostasis comprising a container configured to receive a fibrinogen solution and an activation compartment being situated downstream of the container and comprising a functionalized support to which a coagulation factor, preferably thrombin, is immobilized, such that upon dispensing the fibrinogen solution it passes through the activation compartment, thereby generating and dispensing polymerizing fibrin as a sealant.
Utility
Hollow Fiber Membrane Bundle
12 May 22
The present disclosure relates to bundles of hollow fiber membranes and a process for their production.
Utility
Blood circuit pressure graphical element for medical treatment user interfaces
10 May 22
Graphical user interfaces for use with extracorporeal blood treatment systems may include a blood circuit pressure graphical element.
Transcripts
2022 Q1
Earnings call transcript
28 Apr 22
2021 Q4
Earnings call transcript
17 Feb 22
2021 Q3
Earnings call transcript
28 Oct 21
2021 Q2
Earnings call transcript
29 Jul 21
2021 Q1
Earnings call transcript
29 Apr 21
2020 Q4
Earnings call transcript
4 Feb 21
2020 Q3
Earnings call transcript
29 Oct 20
2020 Q2
Earnings call transcript
30 Jul 20
2020 Q1
Earnings call transcript
30 Apr 20
2019 Q4
Earnings call transcript
17 Mar 20
Reddit threads
Why does NUWE news show up on BAX ?
13 May 22
(4/28) Thursday's Stock Market Movers & News
28 Apr 22
Daily Discussion Thread - April 28th, 2022
28 Apr 22
Daily Discussion Thread - April 27th, 2022
27 Apr 22
Stock Picks from Top Hedge Fund Managers & Top Wall Street Analysts! Top Tickers include: $V $MA $GOOG and $AMZN $GM, $LYFT, $COTY, $NFLX
26 Apr 22
What Are Your Moves Tomorrow, April 27, 2022
26 Apr 22
Daily Discussion Thread - April 26th, 2022
26 Apr 22
Daily Discussion Thread - April 25th, 2022
25 Apr 22
Stock Picks from Top Hedge Fund Managers & Top Wall Street Analysts [from TipRanks] (Some Tickers to look into: $V $MA $GOOG and $AMZN $GM, $LYFT, $COTY, $NFLX)
12 Apr 22
What Are Your Moves Tomorrow, April 05, 2022
4 Apr 22